With the intent of identifying a possible regulatory strategy of the IH pathogenesis, the present study investigated the involvement of the nuclear hormone receptor PPAR-γ in AVF through its modulation by the pharmacological agonist pioglitazone. Here, NR0B1 is linked to isolated hemihyperplasia.